Guardant Health: Great Buy On Dips For Strong Diagnostics Verticals Despite Premium Valuation
Guardant Health has an expanding pipeline that could significantly boost its future market potential. Check out my ...
Arizona State Retirement System Raises Stock Position in Guardant Health, Inc. (NASDAQ:GH)
Arizona State Retirement System grew its holdings in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 1.1% during ...
Guardant Health (GH) Receives a Buy from Barclays
In a report released today, Luke Sergott from Barclays maintained a Buy rating on Guardant Health (GH – Research Report), with a price target ...
StockStory.org on MSN1d
1 Stock Under $50 with Solid Fundamentals and 2 to Turn Down
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They ...
Business Wire9d
Guardant Health Joins Forces With Dak Prescott’s Faith Fight Finish Foundation and Feist-Weiller Cancer Center’s Partners in Wellness to Boost Colon Cancer Screening …
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a collaboration with Dak Prescott’s ...
Nasdaq2d
Guardant Health's Shield Test Secures ADLT Status And Medicare Approval
(RTTNews) - Guardant Health, Inc. (GH) Tuesday announced that the Centers for Medicare & Medicaid Services or CMS has granted Advanced Diagnostic Laboratory Test or ADLT status to its Shield blood ...
Investing2d
Guardant Health at Barclays Conference: Strategic Expansion in Diagnostics
On Wednesday, 12 March 2025, Guardant Health (NASDAQ: GH) participated in the Barclays 26th Annual Global Healthcare Conference, providing a strategic overview of their recent achievements and ...
New blood test for colon cancer offers less invasive option, hopes to increase early detection
There is a new and less invasive option to test for colon cancer and it doesn’t require a stay at the hospital or mailing a ...